"COLPAL: Oral Care Leader – Oversold Zone से Strong Bounce की उम्मीद!"

Detailed Technical Analysis:

Colgate-Palmolive India trades at ₹2,106.70 (+0.8% close Jan 13) after strong intraday bounce from day low ₹2,088.90 (near 52-week low ₹2,033), showing classic oversold reversal with RSI(14) 19.96 (extreme oversold), STOCHRSI 0, Williams %R -94.9, and CCI -175 confirming exhaustion selling from multi-month downtrend. Pivot Points: Classic S1 ₹2,382/S2 ₹2,365/2,365/S3 ₹2,352 | R1 ₹2,412/R2 ₹2,425/R3 ₹2,442 – price holds above S3 support with bullish hammer candle and volume spike (288K vs avg 393K), targeting R1 ₹2,412 (14% upside) above ₹2,120 breakout trigger. MACD(-32.56) divergence + ATR(12.72) contraction signals momentum shift; Strong Buy on hourly/daily oversold bounce amid FMCG defensive rotation, but failure below ₹2,088 risks S3 ₹2,352 retest. Important Events & Impact: Q2FY26 Results (Oct 2025): PAT miss triggered 10% correction to 52-week lows, but oversold bounce underway. Q3FY26 Results (Jan 22): Expected revenue ₹1,550-1,600 Cr (+3-6% QoQ), PAT ₹350 Cr – beat could spark 15% rally to ₹2,400+. Wall Street Top Pick 2026: Morgan Stanley highlights organic sales reacceleration via emerging markets/oral care recovery. Impact: Short-term volatility on results, long-term positive on global FMCG recovery narrative. Morning Rally Continuation? Yes, strong continuation potential – subah ₹2,089 lows se +0.8% close ₹2,106.70 with volume confirmation and oversold indicators aligning perfectly; rally likely sustains above ₹2,120 targeting ₹2,250-2,400 if Q3 optimism builds, supported by hammer reversal and FMCG rotation – momentum intact! Important News: 52-week low bounce: +4% from ₹2,033 to ₹2,106 amid market correction. Morgan Stanley 2026 Top Pick: Sales growth reacceleration expected. Q3 Preview (Jan 22): Analysts eye volume recovery post-pricing slowdown.